Regeneron Pharmaceuticals Statistics

Total Valuation

BMV:REGN has a market cap or net worth of MXN 997.91 billion. The enterprise value is 712.21 billion.

Market Cap	997.91B
Enterprise Value	712.21B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	May 20, 2025

Share Statistics

Current Share Class	103.85M
Shares Outstanding	n/a
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	-2.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	99.75M

Valuation Ratios

The trailing PE ratio is 10.85 and the forward PE ratio is 12.93.

PE Ratio	10.85
Forward PE	12.93
PS Ratio	3.47
PB Ratio	1.66
P/TBV Ratio	1.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.25, with an EV/FCF ratio of 11.23.

EV / Earnings	7.74
EV / Sales	2.64
EV / EBITDA	8.25
EV / EBIT	9.36
EV / FCF	11.23

Financial Position

The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.09.

Current Ratio	4.93
Quick Ratio	3.90
Debt / Equity	0.09
Debt / EBITDA	0.60
Debt / FCF	0.87
Interest Coverage	83.17

Financial Efficiency

Return on equity (ROE) is 15.96% and return on invested capital (ROIC) is 8.04%.

Return on Equity (ROE)	15.96%
Return on Assets (ROA)	6.91%
Return on Invested Capital (ROIC)	8.04%
Return on Capital Employed (ROCE)	11.70%
Revenue Per Employee	18.99M
Profits Per Employee	6.07M
Employee Count	15,106
Asset Turnover	0.39
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.48%
50-Day Moving Average	11,605.07
200-Day Moving Average	15,618.07
Relative Strength Index (RSI)	4.58
Average Volume (20 Days)	76

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.14

Income Statement

In the last 12 months, BMV:REGN had revenue of MXN 287.90 billion and earned 91.96 billion in profits. Earnings per share was 805.86.

Revenue	287.90B
Gross Profit	140.49B
Operating Income	81.25B
Pretax Income	101.87B
Net Income	91.96B
EBITDA	91.38B
EBIT	81.25B
Earnings Per Share (EPS)	805.86

Full Income Statement

Balance Sheet

The company has 170.65 billion in cash and 55.28 billion in debt, giving a net cash position of 304.97 billion.

Cash & Cash Equivalents	170.65B
Total Debt	55.28B
Net Cash	304.97B
Net Cash Per Share	n/a
Equity (Book Value)	600.65B
Book Value Per Share	5,671.86
Working Capital	286.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 80.80 billion and capital expenditures -17.40 billion, giving a free cash flow of 63.40 billion.

Operating Cash Flow	80.80B
Capital Expenditures	-17.40B
Free Cash Flow	63.40B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 48.80%, with operating and profit margins of 28.22% and 31.94%.

Gross Margin	48.80%
Operating Margin	28.22%
Pretax Margin	35.38%
Profit Margin	31.94%
EBITDA Margin	31.74%
EBIT Margin	28.22%
FCF Margin	22.02%

Dividends & Yields

This stock pays an annual dividend of 35.03, which amounts to a dividend yield of 0.37%.

Dividend Per Share	35.03
Dividend Yield	0.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	2.08%
Buyback Yield	-0.13%
Shareholder Yield	0.24%
Earnings Yield	9.22%
FCF Yield	6.35%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:REGN has an Altman Z-Score of 9.55.

Altman Z-Score	9.55
Piotroski F-Score	n/a